Rectal microbicides in development.
Willyard
Cassandra
C
D000285:Administration, Rectal; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage* / Q000009:adverse effects; D017321:Clinical Trials, Phase I as Topic; D015195:Drug Design; D064420:Drug-Related Side Effects and Adverse Reactions; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D012007:Rectum / Q000187:drug effects
D019380:Anti-HIV Agents; D000891:Anti-Infective Agents, Local